A Pilot Efficacy and Safety Study of IPX159 for the Treament of Restless Legs Syndrome.
Phase of Trial: Phase II
Latest Information Update: 03 Apr 2017
At a glance
- Drugs IPX 159 (Primary)
- Indications Restless legs syndrome
- Focus Therapeutic Use
- 12 May 2011 Status changed from not yet recruiting to completed.
- 15 May 2009 New trial record